The study suggests Orforglipron could offer a convenient and accessible option for obesity treatment, especially for those who may face challenges with injectable medications
These symptoms are usually temporary and tend to improve as the body adjusts to GLP-1 medications
Despite lots of big lingering questions, many clinicians dont think it actually matters right now how GLP-1 interacts with brain receptors on a cellular level, says Laura Huckins, PhD, an associate professor of psychiatry at the Yale School of Medicine
moreover, the use of different drugs varies across geographical locations
However, manufacturer assistance programs, insurance coverage, and the Lilly Direct model could bring out-of-pocket costs down to $400 to $600 for many patients